You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Obtenez les dernières mises à jour ou faites une autoévaluation.

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Lignes directrices et conseils
À propos des lignes directrices

Stem Cell Transplantation in Primary Systemic Amyloidosis

Version: 2 ID: SCT-2 nov 2019
Type of Content: Guidelines & Advice, Recommendation Report
Document Status: Current
Authors:
C.T. Kouroukis, R.B. Rumble

Patient Population

Adult patients with primary (AL) amyloidosis who are being considered for treatment that includes either bone marrow or SCT.

Research Question(s)

What is the role of stem cell transplantation (SCT) in the treatment of primary systemic (AL, amyloid light-chain) amyloidosis?

pdf download Summary (PDF) (192.82 Ko)
pdf download Full Report (PDF) (560.92 Ko)